Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

There's a boom in the use of weight loss medications with more new ones on their way, but they are recommended only for the clinically obese. A slew of new weight loss drugs are being tested in 2025.

Ozempic is synonymous with weight loss for ... The use of GLP-1 drugs is associated with an 11% increase in arthritis risk, according to a large study published in Nature Medicine in January ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

But some of the results were unexpected, including how these drugs can help with things ... increased risk of arthritis. via REUTERS Semaglutide — the active ingredient in Ozempic and Wegovy ...

Few drugs have captured public attention like Ozempic; many of us have even taken ... which release GLP-1 when you eat to help control your blood sugar. The relationship with glucose metabolism ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.

A third of weight-loss drug takers also suffered nausea or vomiting and there is an 11 per cent higher risk of developing arthritis ... loss drugs appeared to help reduce the risk of seizures ...

"It will also help them to stop ... The study also suggested that Ozempic and similar drugs can lead to an increase in the risk of nausea and vomiting, as well as arthritis and low blood pressure ...